Since DMD is partly characterised by chronic Ca2+-induced skeletal muscle wasting, Nrf2 activation could effectively rescue functional impairments and convey therapeutic benefits for DMD patients. The gene discussed is NFE2L2; the disease is Duchenne muscular dystrophy.